Boyu Capital General Partner II, L.P. - Net Worth and Insider Trading
Boyu Capital General Partner II, L.P. Net Worth
The estimated net worth of Boyu Capital General Partner II, L.P. is at least $470 Million dollars as of 2025-06-08. Boyu Capital General Partner II, L.P. is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals and owns about 120,080,448 shares of CStone Pharmaceuticals (HKSE:02616) stock worth over $470 Million. Details can be seen in Boyu Capital General Partner II, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Boyu Capital General Partner II, L.P. has not made any transactions after 2025-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Boyu Capital General Partner II, L.P.
Boyu Capital General Partner II, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boyu Capital General Partner II, L.P. owns 1 companies in total, including CStone Pharmaceuticals (HKSE:02616) .
Insider Ownership Summary of Boyu Capital General Partner II, L.P.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02616 | CStone Pharmaceuticals | 2025-06-05 | 2201 Interest of corporation controlled by you |
Boyu Capital General Partner II, L.P. Latest Holdings Summary
Boyu Capital General Partner II, L.P. currently owns a total of 1 stock. Boyu Capital General Partner II, L.P. owns 120,080,448 shares of CStone Pharmaceuticals (HKSE:02616) as of June 3, 2025, with a value of $470 Million.
Latest Holdings of Boyu Capital General Partner II, L.P.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02616 | CStone Pharmaceuticals | 2025-06-03 | 120,080,448 | 3.91 | 469,514,552 |
Holding Weightings of Boyu Capital General Partner II, L.P.
Boyu Capital General Partner II, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, Boyu Capital General Partner II, L.P. has made a total of 4 transactions in CStone Pharmaceuticals (HKSE:02616) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CStone Pharmaceuticals is the sale of 3,994,500 shares on June 3, 2025, which brought Boyu Capital General Partner II, L.P. around $16 Million.
Insider Trading History of Boyu Capital General Partner II, L.P.
- 1
Boyu Capital General Partner II, L.P. Trading Performance
Boyu Capital General Partner II, L.P. Ownership Network
Ownership Network List of Boyu Capital General Partner II, L.P.
Ownership Network Relation of Boyu Capital General Partner II, L.P.
Boyu Capital General Partner II, L.P. Owned Company Details
What does CStone Pharmaceuticals do?
Who are the key executives at CStone Pharmaceuticals?
Boyu Capital General Partner II, L.P. is the 2201 Interest of corporation controlled by you of CStone Pharmaceuticals. Other key executives at CStone Pharmaceuticals include 2201 Interest of corporation controlled by you Boyu Capital Fund II, L.P. , 2201 Interest of corporation controlled by you Boyu Capital General Partner II, Ltd. , and 2201 Interest of corporation controlled by you Boyu Capital Holdings Ltd. .
CStone Pharmaceuticals (HKSE:02616) Insider Trades Summary
Over the past 18 months, Boyu Capital General Partner II, L.P. made 3 insider transaction in CStone Pharmaceuticals (HKSE:02616) with a net sale of 7,028,500. Other recent insider transactions involving CStone Pharmaceuticals (HKSE:02616) include a net purchase of 1,042,500 shares made by Yang Jianxin , a net sale of 7,028,500 shares made by Boyu Capital General Partner II, Ltd. , and a net sale of 7,028,500 shares made by Graceful Beauty Limited .
In summary, during the past 3 months, insiders sold 35,142,500 shares of CStone Pharmaceuticals (HKSE:02616) in total and bought 842,000 shares, with a net sale of 34,300,500 shares. During the past 18 months, 35,292,000 shares of CStone Pharmaceuticals (HKSE:02616) were sold and 1,192,000 shares were bought by its insiders, resulting in a net sale of 34,100,000 shares.
CStone Pharmaceuticals (HKSE:02616)'s detailed insider trading history can be found in Insider Trading Tracker table.
CStone Pharmaceuticals Insider Transactions
Boyu Capital General Partner II, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for Boyu Capital General Partner II, L.P.. Currently GuruFocus does not have mailing address information for Boyu Capital General Partner II, L.P..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
